Biomarkers of Resiliency in Childhood Cancer Surgery

Launched by MAYO CLINIC · Nov 4, 2024

Keywords

ClinConnect Summary

This clinical trial, called "Biomarkers of Resiliency in Childhood Cancer Surgery," is focused on understanding how children and their families recover after major surgery for cancer. The researchers want to find ways to help improve recovery by studying how patients respond to the stress of surgery. They will use smartwatches and questionnaires to gather information about the children's recovery, as well as look at certain proteins and substances in the blood that may indicate stress levels after surgery.

The study is open to children aged 3 to 18 who are having surgery for specific types of solid tumors, such as neuroblastoma or sarcoma. Participants will wear a smartwatch, complete questionnaires, and provide extra blood samples during their regular check-ups for the next year. Importantly, this study won’t change the way their medical care is delivered. Families will be compensated for their time. If you have a child who fits these criteria, this study could provide valuable insights into improving recovery for young cancer patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 3-18 years old at enrollment
• • With solid tumors of the chest, abdomen, and extremities including neuroblastic tumors, sarcoma including soft tissue and bone, kidney tumors, liver tumors, ovarian tumors, lung and pleural-based tumors, and intestinal tumors
• • -OR-
• • Guardian or primary caregiver of patient 3-18 years old with one of the aforementioned tumors.
• Exclusion Criteria:
• • Patients who are known to be pregnant or prisoners.